Effectiveness and safety of sequential transarterial chemoembolization and microwave ablation for subphrenic hepatocellular carcinoma: A comprehensive evaluation

Figure 2 Two patients with cirrhosis and subphrenic hepatocellular carcinoma were treated with transarterial chemoembolization-microwave ablation. A-D: 50-year-old female with cirrhosis and subphrenic hepatocellular carcinoma measuring 5.0 cm in maximum diameter in segment 8 of the liver. Preprocedure axial contrast computed tomography shows a hypervascular tumor in the liver dome (A); coronal enhanced magnetic resonance imaging (MRI) showing suspicious residues within the upper part of the tumor after transarterial chemotherapy with a combination of 30 mg of epirubicin and 5 mL iodized oil (B); 1 mo after the combination treatment, coronal contrast MRI showed that the ablation area encompassed the tumor and was close to the diaphragm (C); 4 years after the combination treatment, coronal contrast MRI showed no residual tumor and significant shrinkage of the ablation area compared with 1-mo postprocedure (D); E-H: 65-year-male with cirrhosis and subphrenic hepatocellular carcinoma measuring 3.2 cm in maximum diameter in segment 7 of the liver. Preoperative axial and coronal contrast MRI showing a hypervascular tumor in the liver dome (E and F); 1 mo after combination treatment, axial and coronal contrast MRI showed that the ablation area encompassed the tumor and was close to the diaphragm and right hepatic vein (G and H).